Prellis employs its proprietary multiphoton holographic bioprinting technology on wide ranging applications that include printing micron-scale biomimetic extracellular matrices.
Our multidisciplinary team has developed lymph node organoids (LNOs™) for rapid in vitro human antibody discovery, tumor disease models, and healthy human tissue models.
Meet The Team
Executive Assistant
Tracy Lash
Operations Management
Andrew Carolan
